Charlotte Marie Niemeyer

Summary

Affiliation: University Hospital
Country: Germany

Publications

  1. ncbi Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia
    Charlotte M Niemeyer
    Department of Pediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany
    Nat Genet 42:794-800. 2010
  2. ncbi Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options
    Charlotte Marie Niemeyer
    Department of Paediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany
    Br J Haematol 140:610-24. 2008
  3. ncbi Myelodysplastic syndrome in children and adolescents
    Charlotte M Niemeyer
    Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Freiburg, Freiburg, Germany
    Semin Hematol 45:60-70. 2008
  4. ncbi EGFR inhibition using gefitinib is not active in neuroblastoma cell lines
    Jochen Rossler
    Department of Pediatrics and Adolescent Medicine, University Hospital of Freiburg, 79106 Freiburg, Germany
    Anticancer Res 29:1327-33. 2009
  5. ncbi Pediatric myelodysplastic syndromes
    Charlotte Marie Niemeyer
    Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Mathildenstrasse 1, 79106 Freiburg, Germany
    Curr Treat Options Oncol 6:209-14. 2005
  6. ncbi Lymphangiogenesis and its regulation in human neuroblastoma
    Jeanette Lagodny
    Division of Pediatric Hematology Oncology, Department of Pediatrics and Adolescent Medicine, Mathilsdenstr 1, 79106 Freiburg, Germany
    Biochem Biophys Res Commun 352:571-7. 2007
  7. ncbi Alveolar rhabdomyosarcoma mimicking lymphoma with bone marrow involvement
    Christof Andreas Hanke
    Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, University of Freiburg, Mathildenstrasse 1, 79106, Freiburg, Germany
    Eur J Pediatr 166:505-6. 2007
  8. ncbi Lethal proliferation of erythroid precursors in a neonate with a germline PTPN11 mutation
    Christian Peter Kratz
    Department of Pediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany
    Eur J Pediatr 165:182-5. 2006
  9. ncbi Myelodysplastic features in an infant with cystic fibrosis presenting with anaemia, oedema and failure to thrive
    Christian Peter Kratz
    Department of Paediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany
    Eur J Pediatr 164:56-7. 2005
  10. ncbi Effect of STI-571 (imatinib mesylate) in combination with retinoic acid and gamma-irradiation on viability of neuroblastoma cells
    Jochen Rossler
    Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University Hospital of Freiburg, Germany
    Biochem Biophys Res Commun 342:1405-12. 2006

Detail Information

Publications13

  1. ncbi Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia
    Charlotte M Niemeyer
    Department of Pediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany
    Nat Genet 42:794-800. 2010
    ....
  2. ncbi Paediatric myelodysplastic syndromes and juvenile myelomonocytic leukaemia: molecular classification and treatment options
    Charlotte Marie Niemeyer
    Department of Paediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany
    Br J Haematol 140:610-24. 2008
    ..Research on genetic conditions predisposing to MDS in young age, such as inherited syndromes with bone marrow failure, may present important insights into MDS pathogenesis...
  3. ncbi Myelodysplastic syndrome in children and adolescents
    Charlotte M Niemeyer
    Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Freiburg, Freiburg, Germany
    Semin Hematol 45:60-70. 2008
    ..Allogeneic hematopoietic stem cell transplantation (HSCT) from a matched related or suitable unrelated donor is the choice for most children with MDS and can rescue a large proportion of patients...
  4. ncbi EGFR inhibition using gefitinib is not active in neuroblastoma cell lines
    Jochen Rossler
    Department of Pediatrics and Adolescent Medicine, University Hospital of Freiburg, 79106 Freiburg, Germany
    Anticancer Res 29:1327-33. 2009
    ..Inhibition of the epidermal growth factor receptor (EGFR), using a tyrosine kinase inhibitor such as gefitinib, was suggested to be a new treatment approach for neuroblastoma...
  5. ncbi Pediatric myelodysplastic syndromes
    Charlotte Marie Niemeyer
    Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Mathildenstrasse 1, 79106 Freiburg, Germany
    Curr Treat Options Oncol 6:209-14. 2005
    ..Unraveling some of the underlying genetic factors predisposing to MDS at a young age may give important insights into leukemogenesis in the elderly...
  6. ncbi Lymphangiogenesis and its regulation in human neuroblastoma
    Jeanette Lagodny
    Division of Pediatric Hematology Oncology, Department of Pediatrics and Adolescent Medicine, Mathilsdenstr 1, 79106 Freiburg, Germany
    Biochem Biophys Res Commun 352:571-7. 2007
    ..We conclude that lymphangiogenesis is involved in NB biology and that siRNA directed against VEGF-C may have a future role in anti-lymphangiogenic strategies in NB...
  7. ncbi Alveolar rhabdomyosarcoma mimicking lymphoma with bone marrow involvement
    Christof Andreas Hanke
    Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, University of Freiburg, Mathildenstrasse 1, 79106, Freiburg, Germany
    Eur J Pediatr 166:505-6. 2007
  8. ncbi Lethal proliferation of erythroid precursors in a neonate with a germline PTPN11 mutation
    Christian Peter Kratz
    Department of Pediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany
    Eur J Pediatr 165:182-5. 2006
    ..In conclusion, this case report suggests that congenital myeloproliferative disorders in association with germline PTPN11 mutations may affect the erythroid lineage...
  9. ncbi Myelodysplastic features in an infant with cystic fibrosis presenting with anaemia, oedema and failure to thrive
    Christian Peter Kratz
    Department of Paediatrics and Adolescent Medicine, University of Freiburg, Freiburg, Germany
    Eur J Pediatr 164:56-7. 2005
  10. ncbi Effect of STI-571 (imatinib mesylate) in combination with retinoic acid and gamma-irradiation on viability of neuroblastoma cells
    Jochen Rossler
    Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University Hospital of Freiburg, Germany
    Biochem Biophys Res Commun 342:1405-12. 2006
    ..Treatment of NB with STI-571 in combination with 9-cis RA might be a therapeutic strategy for patients in consolidation therapy who have completed gamma-irradiation therapy...
  11. ncbi Evaluating systemic prednisone therapy for proliferating haemangioma in infancy
    Jochen Rossler
    Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology and Oncology, University of Freiburg, Freiburg, Germany
    Eur J Pediatr 167:813-5. 2008
    ..For 93% of the children, this protocol was successful in reducing the size of the haemangioma by more than 25% after 2 weeks of treatment. Side effects were moderate and reversible after cessation of therapy...
  12. ncbi Hematologic features and clinical course of an infant with Pearson syndrome caused by a novel deletion of mitochondrial DNA
    Ina Knerr
    Department of Pediatrics, University of Erlangen Nuremberg, Germany
    J Pediatr Hematol Oncol 25:948-51. 2003
    ..371 to 14.607...
  13. ncbi Juvenile myelomonocytic leukemia
    Charlotte Marie Niemeyer
    Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, University of Freiburg, Mathildenstrasse 1, 79106 Freiburg, Germany
    Curr Treat Options Oncol 4:203-10. 2003
    ....